Target Organs and Levels of Evidence for TR-507
Toxicology and Carcinogenesis Studies of Vanadium Pentoxide (CASRN 1314-62-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies)
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Vanadium pentoxide 1314-62-1 |
Inhalation R&M: 0.0, 1.0, 2.0, 4.0, 8.0, OR 16 MG/M3 (10/S/S) |
IIT Research Institute |
Levels of Evidence: None
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Vanadium pentoxide 1314-62-1 |
10/18/2001 | Inhalation R: 0, 0.5, 1, OR 2 MG/M3 M: 0, 1, 2, OR 4 MG/M3; 70/SEX/SPECIES/GROUP |
Battelle Northwest Laboratory |
Levels of Evidence
Male Rats: Some Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|
Female Rats: Equivocal Evidence
Type | Organ/Tissue (Lesion) |
---|---|
May Have Been Related |
|
Non-Neoplastic Lesions |
|
Male Mice: Clear Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|
Female Mice: Clear Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|